(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

COPD without smoking? New data reveal unexpected symptoms and inflammation patterns. Read more to see what this means for ...

AstraZeneca shares were up about 3.5% Friday after the company said its drug for COPD, a deadly lung disease often caused by smoking, slowed patients' symptoms in two large trials. The drug, ...

The first one was that several participants did not know the correct inhaler regimen that they were actively prescribed at ...

If you're experiencing cold or flu-like symptoms this winter – your symptoms may be linked to a lesser-known respiratory ...

Patients with respiratory conditions, such as asthma and COPD, are being encouraged to use apps to manage their symptoms.

For women over 40, certain common symptoms could be signs of an underlying health condition. Learn more about what to watch for.

After Asha Bhosle’s death from chest infection, doctors explain symptoms, warning signs, stages and treatment, especially ...

There are two types of inflammation: acute and chronic. Acute inflammation is the kind that lasts a few hours, days, or weeks, and it’s helpful to healing. It’s your immune system’s response when ...

AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has hit the mark in a pair of phase 3 trials, delivering broad efficacy with a mechanism that yielded mixed data for Roche and ...

AstraZeneca's IL-33-targeting antibody tozorakimab has made the grade in two phase 3 chronic obstructive pulmonary disease (COPD) trials, raising the prospects of a class that has recorded some ...

The common wisdom about catching a virus is that in a few days—a few weeks, tops—everything will be back to normal. And in many cases, that’s true. But as the flood of Long COVID cases during the ...